[theold]

BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than expected data gathering process.

"If the wave ends, that does not mean it can't begin again," he told Bild in a video interview, adding that BioNTech was in a position to continue creating new vaccines as variants emerged if needed.

https://www.reuters.com/business/healthc...022-02-16/